Standout Papers

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir 2022 2026 2023 2024243
  1. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir (2022)
    Sho Iketani, Hiroshi Mohri et al. Nature

Immediate Impact

7 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Three-year outcomes of post-acute sequelae of COVID-19
2024 Standout
1 intermediate paper

Works of Bruce Culbertson being referenced

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
2022 StandoutNature

Author Peers

Author Last Decade Papers Cites
Bruce Culbertson 291 215 51 101 10 519
Mehdi Bouhaddou 294 183 79 53 23 546
Muxue Tang 243 181 54 76 13 558
Liyang Ma 199 284 122 52 12 560
Junwen Luan 142 337 73 72 15 595
Sajjan Rajpoot 284 137 147 104 17 539
Shih-Chieh Su 272 190 32 35 19 508
John Bechill 212 300 73 96 9 609
Yu-Jen Jou 175 134 78 24 9 482
Tao Jiao 235 134 98 35 16 471
Sravan Kumar Miryala 334 89 35 115 18 512

All Works

Loading papers...

Rankless by CCL
2026